Stock Analysis·← Pickers

STIM

Neuronetics, Inc.

Neuronetics, Inc. (STIM) is currently in a range/mixed trend, trading above both the 50-day and 200-day moving averages. RSI is at 72.5 (overbought), with 2/3 trend checks passing.

Price
$1.84
2026-07-16
Trend score
2/3
Range / Mixed
RSI (14)
72.5
Overbought
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

STIM with MA50 and MA200

4.663.792.922.051.1807/3110/2401/2204/1707/15
STIM2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$1.44+28.15% vs price
MA200
$1.73+6.62% vs price
RSI (14)
72.5Overbought zone
MACD Signal
BullishMomentum above signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for STIM

Neuronetics, Inc. (STIM) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $1.84, and 2 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 28.2% and above the 200-day moving average by 6.6%.

Momentum and stretch context

STIM currently has an RSI reading of 72.5, which suggests stronger momentum and a more stretched short-term backdrop. Trend traders may still find that attractive, while more patient traders may prefer to wait and see whether the stock cools off first.

What traders may watch next

Because STIM is showing stronger momentum inside a more extended backdrop, the next step is often about timing rather than direction. A stock can keep pushing higher, but many traders will still watch for whether the move stays orderly or starts to look too stretched to offer a comfortable entry.

Company profile

About Neuronetics, Inc.

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Daniel L. Reuvers
Employees
658
Market cap
$128.0M
Beta
1.06
52-week range
$0.80 – $4.85
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
28 Jun 2018
ISIN
US64131A1051
CUSIP
64131A105
Company profile data from Financial Modeling Prep. STIM listed on NASDAQ.
Share dilution

STIM shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
69.6M
Since Jun 2019
+279.2%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. STIM28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about STIM

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.